Bio-Techne (TECH) capital expenditure was $29M in FY2026 (-7% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2026
$29M
-7%
2025
$31M
-51%
2024
$63M
+64%
2023
$38M
-15%
2022
$45M
+1%
2021
$44M
-14%
2020
$52M
+104%
2019
$25M
+21%
2018
$21M
+38%
2017
$15M
-10%
2016
$17M
-15%
2015
$20M
+44%
2014
$14M
-38%
2013
$22M
+273%
2012
$6M
+66%
2011
$4M
-22%
2010
$5M
-29%
2009
$7M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$8M
Q1 2026
$9M
Q4 2025
$6M
Q3 2025
$5M
Q2 2025
$5M
Q1 2025
$10M
Q4 2024
$7M
Q3 2024
$9M
Q2 2024
$18M
Q1 2024
$16M
Q4 2023
$15M
Q3 2023
$14M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.